Several studies have demonstrated that using antimiRs conjugated with cell-penetrating peptides effectively increases endogenous MBNL1 protein levels, improving splicing defects and muscle function phenotypes in DM1 cell and mouse models (184). This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.